Literature DB >> 17350729

Inactivation of Norovirus by ozone gas in conditions relevant to healthcare.

J B Hudson1, M Sharma, M Petric.   

Abstract

We evaluated the ability of ozone gas to inactivate Norovirus and its animal surrogate feline calicivirus (FCV) in dried samples placed at various locations within a hotel room, a cruise liner cabin and an office. Norovirus was measured by quantitative reverse transcriptase real-time polymerase chain reaction (QRT-PCR) assay, and FCV by a combination of QRT-PCR and virus infectivity assays. We were able to reduce the concentration of infectious FCV by a factor of more than 10(3), and in some cases beyond detection, under optimal conditions of ozone exposure with less than an hour of total operation. QRT-PCR assays indicated similar decreases in both viral RNAs. Virus-containing samples dried onto hard surfaces (plastic, steel and glass), and soft surfaces such as fabric, cotton and carpet, were equally vulnerable to the treatment. Our results show that Norovirus can be inactivated by exposure to ozone gas from a portable commercial generator in settings such as hotel rooms, cruise ship cabins and healthcare facilities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17350729     DOI: 10.1016/j.jhin.2006.12.021

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  24 in total

1.  Ozone generated by air purifier in low concentrations: friend or foe?

Authors:  Larissa Vivan Cestonaro; Ana Maria Marcolan; Luciana Grazziotin Rossato-Grando; Ana Paula Anzolin; Gabriela Goethel; Angélica Vilani; Solange Cristina Garcia; Charise Dallazem Bertol
Journal:  Environ Sci Pollut Res Int       Date:  2017-08-16       Impact factor: 4.223

Review 2.  Review of Decontamination Techniques for the Inactivation of Bacillus anthracis and Other Spore-Forming Bacteria Associated with Building or Outdoor Materials.

Authors:  Joseph P Wood; Alden Charles Adrion
Journal:  Environ Sci Technol       Date:  2019-04-02       Impact factor: 9.028

Review 3.  Infection control for norovirus.

Authors:  L Barclay; G W Park; E Vega; A Hall; U Parashar; J Vinjé; B Lopman
Journal:  Clin Microbiol Infect       Date:  2014-07-16       Impact factor: 8.067

Review 4.  Critical review of norovirus surrogates in food safety research: rationale for considering volunteer studies.

Authors:  Gary P Richards
Journal:  Food Environ Virol       Date:  2011-12-09       Impact factor: 2.778

5.  Ionizing air affects influenza virus infectivity and prevents airborne-transmission.

Authors:  Marie Hagbom; Johan Nordgren; Rolf Nybom; Kjell-Olof Hedlund; Hans Wigzell; Lennart Svensson
Journal:  Sci Rep       Date:  2015-06-23       Impact factor: 4.379

6.  Inactivation of a foodborne norovirus outbreak strain with nonthermal atmospheric pressure plasma.

Authors:  Birte Ahlfeld; Yangfang Li; Annika Boulaaba; Alfred Binder; Ulrich Schotte; Julia L Zimmermann; Gregor Morfill; Günter Klein
Journal:  mBio       Date:  2015-01-13       Impact factor: 7.867

7.  New Proof-of-Concept in Viral Inactivation: Virucidal Efficacy of 405 nm Light Against Feline Calicivirus as a Model for Norovirus Decontamination.

Authors:  Rachael M Tomb; Michelle Maclean; John E Coia; Elizabeth Graham; Michael McDonald; Chintamani D Atreya; Scott J MacGregor; John G Anderson
Journal:  Food Environ Virol       Date:  2016-12-31       Impact factor: 2.778

8.  The use of ozone gas for the inactivation of Bacillus anthracis and Bacillus subtilis spores on building materials.

Authors:  Joseph P Wood; Morgan Wendling; William Richter; James Rogers
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

9.  CORonavirus-19 mild to moderate pneumonia Management with blood Ozonization in patients with Respiratory failure (CORMOR) multicentric prospective randomized clinical trial.

Authors:  Emanuela Sozio; Amato De Monte; Giovanni Sermann; Flavio Bassi; Davide Sacchet; Francesco Sbrana; Andrea Ripoli; Francesco Curcio; Martina Fabris; Stefania Marengo; Daniele Italiani; Daniela Luciana Boccalatte-Rosa; Carlo Tascini
Journal:  Int Immunopharmacol       Date:  2021-06-12       Impact factor: 5.714

10.  Inactivation of caliciviruses.

Authors:  Raymond Nims; Mark Plavsic
Journal:  Pharmaceuticals (Basel)       Date:  2013-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.